Alzheimer’s Therapeutics Market to Nearly Double by 2032 on Rising Disease Burden and Breakthrough Treatments Alzheimer’s Therapeutics Market, valued at USD 6.28 billion in 2024, is expected to grow at a robust compound annual growth rate (CAGR) of around 8.27% through 2032, driven by an increasing global prevalence of Alzheimer’s disease as populations age and by the...